Please assess the completion status of the following clinical trial:

Trial Title: Oral Glutathione Supplementation on the Levels of Blood Glutathione

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male and females between the ages of 30 and 79 years of age~* Not taking glutathione as a dietary supplement~* Not taking high dose antioxidant supplement prior to 1 month~* Baseline blood glutathione level of \< 1 mmol/L~Exclusion Criteria:~* History or evidence of disease including cancer, diabetes, heart disease~* Subjects who smoke

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 79 Years
- Healthy Volunteers: t

Study Arms:
- Group A (Type: EXPERIMENTAL): Glutathione supplementation-Double-Blind - GSH 500 mg/GSH 125 mg/Placebo~Other name Gluthathione peroxidases
- Group B (Type: EXPERIMENTAL): Glutathione supplementation-Double-Blind - GSH 500 mg/GSH 125 mg/Placebo~Other name Gluthathione peroxidases
- Group C (Type: PLACEBO_COMPARATOR): Placebo-Double-Blind - GSH 500 mg/GSH 125 mg/Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).